10 completed, 4 unknown. 13 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 13 | Completed 10, Unknown 3 |
Follow Gelesis, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing GS500 in Functional Constipation GS500, Placebo - Constipation - Functional | Not applicable | Unknown | Gelesis, Inc. | 260 | 2022-07-15 | 2022-01-24 |
| Study on GS300 on NAFLD GS300, Placebo - Nonalcoholic Fatty Liver, Weight Loss | Not applicable | Unknown | Gelesis, Inc. | 250 | 2022-07-01 | 2022-01-24 |
| Primary Hepatobiliary Cancer Cohort of Central China Hepatocellular Carcinoma, Biliary Tract Neoplasms | Unknown | Tongji Hospital | 2000 | 2020-05-01 | 2023-12-19 | |
| SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY) Gelesis100, Placebo - Appetitive Behavior | Not applicable | Completed | Purdue University | 31 | 2020-01-07 | 2022-04-19 |
| Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP Gelesis200, Placebo, Gelesis200 and Placebo - Overweight and Obesity, PreDiabetes | Not applicable | Completed | Gelesis, Inc. | 16 | 2017-08-22 | 2022-04-04 |
| Gelesis Glycemic Index Study Gelesis200, Water, only (placebo) - Obesity, Diabetes | Not applicable | Completed | Gelesis, Inc. | 20 | 2017-04-18 | 2018-02-15 |
| The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation CSP01, Carboxymethylcellulose (CMC), Placebo - Constipation, Chronic Idiopathic Constipation | Not applicable | Completed | Massachusetts General Hospital | 52 | 2017-03-07 | 2019-08-20 |
| Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes Gelesis200, Placebo - Overweight, Diabetes | Not applicable | Unknown | Gelesis, Inc. | 300 | 2017-02-22 | 2020-07-21 |
| Extension Study of Gelesis100 on Body Weight Gelesis100 (2.25 g) - Overweight and Obesity | Not applicable | Completed | Gelesis, Inc. | 36 | 2017-01-25 | 2018-02-22 |
| Gelesis200 Safety and Tolerability Study and Effects on Glycemic and Appetite Parameters Gelesis200, Placebo - Healthy Overweight Obese | Not applicable | Completed | Gelesis, Inc. | 24 | 2016-01-01 | 2016-05-09 |
| A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects Gelesis100, Placebo - Overweight, Obesity | Not applicable | Completed | Gelesis, Inc. | 16 | 2015-09-01 | 2016-08-23 |
| The Effect of Gelesis100 on the Pharmacokinetics of Metformin Gelesis100, Metformin - Healthy Overweight Obese | Not applicable | Completed | Gelesis, Inc. | 24 | 2015-09-01 | 2018-06-26 |
| Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes Gelesis100, placebo - Overweight, Obesity | Not applicable | Completed | Gelesis, Inc. | 436 | 2014-11-01 | 2022-08-30 |
| Effect of GSP3 on Body Weight in Overweight and Obese Subjects GSP3, Avicel (modified Cellulose) - Overweight, Obesity | Not applicable | Completed | Gelesis, Inc. | 128 | 2012-07-01 | 2018-05-15 |
Obesity (7) · Overweight (6) · Prediabetic State (3) · Diabetes Mellitus (2) · Weight Loss (2) · Appetitive Behavior (1) · Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Constipation (1) · Non-alcoholic Fatty Liver Disease (1)
Cellulose (1) · Metformin (1) · Single Person (1) · Water (1) · hydroxypropylcellulose (1) · maltodextrin (1) · microcrystalline cellulose (1)
Canada (5) · Denmark (5) · United States (5) · Czechia (4) · Italy (4) · Spain (2) · United Kingdom (2) · China (1) · Hungary (1) · Poland (1)
Hassan Heshmati, MD (3) · Hassan M Heshmati, MD (2) · Bixiang Zhang (1) · Hassan M Heshmati, M.D. (1) · Kyle Staller, MD, MPH (1) · Zeyang Ding (1)